Search Results
ASCO 2021: Latest on PARPi and other treatments for mCRPC
ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022
mCRPC: Latest developments in diagnostics and combination therapies
ESMO 2021: PARPi data and their role in mono/combination therapies
PARPi in PC - Case based testing and clinical decisions
PARP inhibitors for the treatment of metastic castration-resistant prostate cancer
The evolving treatment landscape of mHSPC and mCRPC
Point-Counterpoint: Management of mCRPC
Castration Resistant Prostate Cancer - Developments and Challenges from 2020
Role of PARP Inhibitors in Prostate Cancer
PARPi for somatic BRCA1/2 and other DNA repair gene mutations in women with metastatic breast cancer
PROpel trial
